Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2021

Jul 8, 2021

30253_dirs_2021-07-07_0e0ab155-9214-43e4-8b6a-6a74de1a5891.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-07-02

Reporting Person: Chapman Steven Leonard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-02 Common Stock M 3125 Acquired 77755 Direct
2021-07-02 Common Stock M 9375 Acquired 87130 Direct
2021-07-06 Common Stock S 1558 $118.59 Disposed 85572 Direct
2021-07-06 Common Stock M 2404 $9.29 Acquired 87976 Direct
2021-07-06 Common Stock M 2370 $13.01 Acquired 90346 Direct
2021-07-06 Common Stock M 8203 $13.01 Acquired 98549 Direct
2021-07-06 Common Stock M 2370 $20.27 Acquired 100919 Direct
2021-07-06 Common Stock M 4922 $25.46 Acquired 105841 Direct
2021-07-06 Common Stock M 27 $10.73 Acquired 105868 Direct
2021-07-06 Common Stock S 6045 $116.4325 Disposed 99823 Direct
2021-07-06 Common Stock S 13543 $117.1280 Disposed 86280 Direct
2021-07-06 Common Stock S 708 $118.3725 Disposed 85572 Direct
2021-07-06 Common Stock S 2835 $116.5901 Disposed 82737 Direct
2021-07-06 Common Stock S 3126 $117.2364 Disposed 79611 Direct
2021-07-06 Common Stock S 17 $118.59 Disposed 79594 Direct
2021-07-07 Common Stock S 4633 $117.98 Disposed 74961 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-02 Restricted Stock Unit $ M 3125 Disposed Common Stock (3125) Direct
2021-07-02 Restricted Stock Unit $ M 9375 Disposed Common Stock (9375) Direct
2021-07-06 Stock Option (right to buy) $9.29 M 2404 Disposed 2028-03-08 Common Stock (2404) Direct
2021-07-06 Stock Option (right to buy) $13.01 M 2370 Disposed 2029-01-10 Common Stock (2370) Direct
2021-07-06 Stock Option (right to buy) $13.01 M 8203 Disposed 2029-01-10 Common Stock (8203) Direct
2021-07-06 Stock Option (right to buy) $20.27 M 2370 Disposed 2029-04-11 Common Stock (2370) Direct
2021-07-06 Stock Option (right to buy) $25.46 M 4922 Disposed 2030-03-26 Common Stock (4922) Direct
2021-07-06 Stock Option (right to buy) $10.73 M 27 Disposed 2027-07-13 Common Stock (27) Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") starting January 2, 2020.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: Represents the partial vesting and settlement of RSUs starting October 1, 2020.

F4: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.

F5: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021

F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.75 to $116.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.76 to $117.6150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.82 to $118.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.91 to $116.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.97 to $117.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.

F12: On March 27, 2020, the Reporting Person was granted a RSU, which vests in three tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Issuer's stock price. On July 2, 2021, the Issuer's Board of Directors determined that the milestone for the second tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.

F13: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.

F14: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F15: This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to 31,250 additional shares.

F16: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F17: The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.

F18: The option shares are fully vested and may be exercised at any time.